Skip to main content

Fundamentals-first equity research for GCC markets

Screener Disclosures Contact Us Privacy Policy Terms of Use

© 2026 premargin. All rights reserved.

LinkedIn X Instagram

Research updates, no noise

you@example.com Research updates, no noise

you@example.com

4015 Disclosures - Jamjoom Pharmaceuticals Factory Co. | premargin

Qatar Index10,021.90-1.4%

DFM Index5,510.99-0.1%

TASI11,078.89-0.1%

Emirates NBD27.60-3.2%

Dubai Electricity & Water Authority2.65+0.4%

EMAAR12.10-0.4%

EMAARDEV13.750.0%

ADNOC GAS3.240.0%

First Abu Dhabi Bank17.38-1.0%

Emirates Telecom18.78+0.6%

Abu Dhabi Commercial Bank12.64+0.8%

ALRAJHI104.10-0.2%

MAADEN63.70-1.2%

SABIC58.40-0.9%

Boubyan Bank0.68-0.6%

GULF BANK0.33+0.6%

Commercial Bank Of Kuwait0.47-3.3%

Burgan Bank0.210.0%

Industries Qatar10.66-1.8%

Qatar Islamic Bank22.32-1.2%

Ooredoo12.19-3.5%

Qatar Index10,021.90-1.4%

DFM Index5,510.99-0.1%

TASI11,078.89-0.1%

Emirates NBD27.60-3.2%

Dubai Electricity & Water Authority2.65+0.4%

-0.4%

EMAARDEV13.750.0%

ADNOC GAS3.240.0%

First Abu Dhabi Bank17.38-1.0%

Emirates Telecom18.78+0.6%

Abu Dhabi Commercial Bank12.64+0.8%

ALRAJHI104.10-0.2%

MAADEN63.70-1.2%

SABIC58.40-0.9%

Boubyan Bank0.68-0.6%

GULF BANK0.33+0.6%

Commercial Bank Of Kuwait0.47-3.3%

Burgan Bank0.210.0%

Industries Qatar10.66-1.8%

Qatar Islamic Bank22.32-1.2%

Ooredoo12.19-3.5%

JAMJOOM PHARMA

Jamjoom Pharmaceuticals Factory Co.

4015StocksTadawulHealthcare

Overview Financials Dividends Disclosures

Disclosures

Market closed

SAR 144.80

Official close

+2.0%

Price as of March 29, 2026 · Market close

Prices may be delayed by up to 30 minutes.

Showing 10 of 29 results

Jamjoom Pharmaceuticals Factory Co. announces the board of director’s decision to distribute cash dividends for Second half of 2025 (Six months)

Jamjoom Pharmaceuticals Factory Co.·Tadawul·Healthcare·News·February 24, 2026

Jamjoom Pharmaceuticals Factory Co. announces its Annual Financial results for the period ending on 31-12-2025

Jamjoom Pharmaceuticals Factory Co.·Tadawul·Healthcare·Financial Reports·February 24, 2026

Jamjoom Pharmaceuticals Factory Co. Announces providing a corporate guarantee to its Joint Venture in Algeria

Jamjoom Pharmaceuticals Factory Co.·Tadawul·Healthcare·News·January 18, 2026

Jamjoom Pharmaceuticals Factory Co. announces the Board of Directors' recommendation to transfer the entire balance of the statutory reserve to retained earnings

Jamjoom Pharmaceuticals Factory Co.·Tadawul·Healthcare·News·January 1, 2026

Jamjoom Pharmaceuticals Factory Co. announces the Signing of a Non-Binding Term Sheet with Pharmaceutical Investment Company, in relation to a potential strategic partnership

Jamjoom Pharmaceuticals Factory Co.·Tadawul·Healthcare·News·October 27, 2025

Jamjoom Pharmaceuticals Factory Co. announces its Interim Financial results for the Period Ending on 2025-09-30 ( Nine Months )

Jamjoom Pharmaceuticals Factory Co.·Tadawul·Healthcare·Financial Reports·October 23, 2025

Jamjoom Pharmaceuticals Factory Co. announces its intention to release its 3rd quarter financial results for the period ended 30 September 2025 on Thursday, October 23rd 2025, before the trading session begins on the Saudi Exchange

Jamjoom Pharmaceuticals Factory Co.·Tadawul·Healthcare·Financial Reports·October 16, 2025

Jamjoom Pharmaceuticals Factory Co. announces the board of director’s decision to distribute cash dividends for First half of 2025 (Six months)

Jamjoom Pharmaceuticals Factory Co.·Tadawul·Healthcare·News·July 24, 2025

Jamjoom Pharmaceuticals Factory Co. announces its Interim Financial results for the Period Ending on 2025-06-30 ( Six Months )

Jamjoom Pharmaceuticals Factory Co.·Tadawul·Healthcare·Financial Reports·July 24, 2025

Jamjoom Pharmaceuticals Factory Co. Announces its intention to release its second quarter financial results for the period ended 30 June 2025 on Thursday, July 24, 2025, before the trading session begins on the Saudi Exchange

Jamjoom Pharmaceuticals Factory Co.·Tadawul·Healthcare·Financial Reports·July 15, 2025